digital-biomarkers-neurology.com
Open in
urlscan Pro
5.134.13.35
Public Scan
Submitted URL: https://bit.ly/3vfsyLD
Effective URL: https://digital-biomarkers-neurology.com/?utm_source=external&utm_medium=remarketing&utm_campaign=brochure&utm_content=media-partner/phar...
Submission: On April 27 via manual from US — Scanned from DE
Effective URL: https://digital-biomarkers-neurology.com/?utm_source=external&utm_medium=remarketing&utm_campaign=brochure&utm_content=media-partner/phar...
Submission: On April 27 via manual from US — Scanned from DE
Form analysis
1 forms found in the DOMGET https://digital-biomarkers-neurology.com/
<form role="search" method="get" id="searchform" class="searchform" action="https://digital-biomarkers-neurology.com/">
<div>
<label class="screen-reader-text" for="s"> Search</label>
<input type="text" value="" name="s" id="s" placeholder="">
<input type="submit" id="searchsubmit" value="Search">
</div>
</form>
Text Content
Skip to content JULY 11-13 BOSTON, MA, USA Register by Friday, April 29 & Save Up to $1000 Menu * Home * About * About Event * Venue * Program * Full event guide * Speakers * Pre-Conference Workshop Discussions Day * Agenda * Partnership * Partnership Opportunities * Partners * Get involved * Register * Pricing * Contact us FULL EVENT GUIDE PARTNER REGISTER NOW MORE OBJECTIVELY, FREQUENTLY & SENSITIVELY DIAGNOSE & MONITOR PATIENTS TO ROBUSTLY PROVE DRUG EFFICACY IN NEUROLOGICAL TRIALS Critical advances in device design, data collection, and algorithm development are redefining the landscape for integrating digital technologies into neurological clinical trials to monitor disease progression, establish therapeutic efficacy, and aid diagnosis. In the context of inherent disease complexity and vast heterogeneity across populations leading to the industry’s highest clinical failure rate, industry progress needs a biomarker revolution to take the next step in bringing meaningful treatment options to patients, but what are the next steps in developing, integrating, and validating digital biomarkers in neurological trials? Uniting industry experts dedicated to implementing digital biomarkers in Neurodegenerative, Movement and Neuropsychiatric Disorders clinical trials, the Digital Biomarkers & Clinical Measures in Neurology Summit is the definitive industry forum sharing cross-industry insight to transform clinical development with digital data. From integrating wearable technologies, smartphone apps, and speech-based digital biomarkers into remote clinical research to elucidating pathways to clinical validation to establish therapeutic efficacy, join industry experts from Merck, Janssen, GSK, Sanofi, Novartis, Takeda, Eli Lilly & Company, Mitsubishi Tanabe Pharma Holdings America and many more to improve patient retention and establish efficacy with richer datasets. 2022 EVENT GUIDE EXPERT SPEAKERS INCLUDE: AMIR LAHAV Head of Digital R&D, Digital Healthcare Innovation Mitsubishi Tanabe Pharma Holdings America ANKITA DESHPANDE Head of Innovation Accelerator Alexion LAUREN LI Global Head of Digital Health Ipsen SACHIN SHAH Global Medical Partner, Digital Health & Devices GSK BERNARD HAMELIN Former Vice President, Head of Evidence Generation Sanofi JIAN YANG Associate Vice President, Digital Health Eli Lilly & Company KARLA ALLEBRANDT Director, Senior Clinical Biomarker Lead CNS Boehringer Ingelheim NICK BOTT Global Head, Bioethics, Technology Ethics & Responsible Innovation Takeda VIEW THE FULL SPEAKER FACULTY TESTIMONIALS: 1 2 3 4 5 OUR CONTACT DETAILS T: +1 617 455 4188 E: info@hansonwade.com VENUE DETAILS The Bostonian 26 North St, Boston MA 02109 United States ABOUT US Hanson Wade's goal is to accelerate progress within organisations and across industries. Our primary method for achieving this is by creating exclusive business conferences that gather together the world's smartest thinkers and doers. LOCATION SEARCH Search ORGANISED BY Terms & Conditions Privacy Policy © Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216. Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH. We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok